Company page
Lumosa Therapeutics Co Ltd
Lumosa Therapeutics Co Ltd, trading under the ticker 6535, is a public company based in Taiwan with a market capitalization of approximately NT$545 million. The company focuses on developing innovative therapies to address unmet medical needs. Lumosa is committed to advancing its research and development efforts in the biopharmaceutical sector.
- Ticker
- 6535:TPEX
- Asset type
- Stock
- Market cap
- $545.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TPEX
- Currency
- TWD